Pure Global AI
Botswana flag

Botswana medical device registration timeline

Source-linked clocks

Botswana Medicines Regulatory Authority (BoMRA) review clocks and end-to-end planning ranges, using the 4-class (A, B, C and D) for medical devices excluding IVDs under BOMRA/ER/MED/P04/G05, and a separate 4-class (A, B, C and D) individual/public-health-risk axis for IVDs under BOMRA/ER/MED/P04/G06 — both GHTF/IMDRF-derived classification system.

7 pathways7 of 7 clocks verifiedvalidity 5 years unless suspended or revoked by BoMRA or terminated by the registrant, subject to annual retention fees, post-marketing surveillance reports and adverse-effect reports; renewal must be applied for six months before expiryMDSAP not acceptedreviewed 2026-09-16
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Screening — all registration routes (Notification, Class A and B, Class C, Class D)(Application for screening lodged with the applicable screening fee through the BRIMS Self Service Portal; approval of the screening step is what allows the applicant to submit the evaluation application)

G01 s.4.15 publishes the screening target per route: 'Within 3 months' for the notification pathway, 'Within 1 month' for Class A and B, and 'Within 2 months' for Class C and 'Within 2 months' for Class D. The row publishes that published ladder as a range rather than picking one class.

Two query cycles are allowed. Once a query is raised the processing halts until the response is received, and if no response is received within the timeline specified in s.4.15 the application is deemed withdrawn by the applicant (G01 s.4.8(ii)).

Only after the screening step is approved does the applicant submit the evaluation application, and the s.4.15 evaluation clocks run from the accepted evaluation application with the evaluation fee paid.

1-3 months2-5 months—Verified
Abridged evaluation — Class B, C and D (proof of a reference regulatory agency required)(Abridged evaluation route for Class B, C and D, whose dossier must additionally carry proof of the Reference Regulatory Agency and proof of that agency's marketing authorisation)

G01 s.4.15 publishes the abridged target as Class A and B 'Within 4 months', Class C 'Within 6 months' and Class D 'Within 8 months', with 'NA' for the notification route; the row carries the published ladder as a range.

The abridged route is the one route where a foreign approval does work: G01 Table 3 marks 'Proof of Reference Regulatory Agency' and 'Proof of Marketing Reference Regulatory Agency' as required for the abridged dossier and not required for the full dossier, which makes those two documents the eligibility evidence for entering the shorter route.

A Reference Regulatory Authority is defined in G01 s.3.1.25 as an NRA recognised by BoMRA under its policy 'Recognition and-or Reliance on Information on Medical Devices including IVDs from Regional and International Regulatory Agencies' — a policy this review did not retrieve, so the list of recognised authorities is not asserted here.

4-8 months8-14 months—Verified
Full evaluation — Class B, C and D, local manufacturer(Full evaluation route for a device manufactured in Botswana, with the complete Summary Technical Documentation dossier under G01 ss.6-8)

G01 s.4.15 publishes the full-evaluation target for local manufacturers as Class A and B 'Within 6 months', Class C 'Within 8 months' and Class D 'Within 10 months'; the row carries that published ladder as a range.

The full dossier requires, among other items, the Declaration of Conformity, the Certificate of Compliance with Recognized Standards, medical-device quality-management-system evidence, a post-market surveillance plan, an executive summary, the Summary Technical Documentation and device labelling (G01 Table 3).

Registration is site specific (G01 s.4.9) and a quality-system audit of the manufacturing site may be conducted as part of the evaluation (G01 s.4.8(v)).

6-10 months10-16 months—Verified
Full evaluation — Class B, C and D, foreign manufacturer(Full evaluation route for a device manufactured outside Botswana, filed through a Local Technical Representative and submitted electronically through the BRIMS Self Service Portal)

G01 s.4.15 publishes the full-evaluation target for a foreign manufacturer as Class A and B 'Within 8 months', Class C 'Within 10 months' and Class D 'Within 12 months'; the row carries that ladder as a range. This is the route a foreign device manufacturer uses unless it qualifies for the abridged route.

Where the applicant is not resident in Botswana it must appoint a Local Technical Representative (also called an Authorized Representative) that is a company residing or incorporated in Botswana, and the LTR is the applicant of record (G01 s.3.1.3).

Applications for renewal must be made six months before the existing registration expires (G01 s.4.14), so a registrant has to re-enter the dossier cycle well before the five-year term ends.

8-12 months1-1.7 years—Verified
Expedited evaluation — Class B, C and D(Expedited evaluation route for Class B, C and D under G01 s.4.15)

G01 s.4.15 publishes the expedited target as Class A and B 'Within 4 months', Class C 'Within 6 months' and Class D 'Within 8 months'. The expedited clock is the same as, or close to, the abridged clock, so expediting buys little over a supported abridged filing.

G01 does not publish the criteria for granting expedited evaluation, and no expedited fee head exists in the in-force schedule, so the route is described here only as the guideline states it.

4-8 months6-12 months—Verified
WHO Collaborative Registration Procedure — all classes(Registration through the WHO Collaborative Registration Procedure, with the WHO PQ documentation submitted with the application)

G01 s.4.15 publishes a single 'WHO CRP — Within 3 months' row with no class columns, which is why this row carries a route-wide exemption rather than a class link. It is the shortest published route in Botswana.

The guideline adds a filing condition rather than only a clock: for WHO PQ medical devices the manufacturer has to submit a filled form 2 and form 3 along with the application (G01 s.4.8(vi)).

G01 s.4.15's periods are target assessment times; the clock stops while a query is outstanding (G01 s.4.8(ii)).

3 months3-8 months—Verified
Post-registration variation — major, minor and notification(Variation application to a registered device under the Medical Devices Variation Guidelines (BOMRA/ER/MED/P09/G01) referenced by G01 s.4.13, with a new dossier required where the change is fundamental)

G01 s.4.15 publishes 'Major Variations — Within 3 months', 'Minor Variations — Within 3 months' and 'Notification variations — Within 1 Month'; the variation ladder is by variation type, not by device risk class, which is why the row carries a route-wide exemption.

The registered holder must inform the Authority of any significant change that could reasonably be expected to affect safety or effectiveness, and certain fundamental changes cannot be handled as a variation at all — a new dossier must be submitted (G01 s.4.13).

1-3 months2-5 months—Verified
Review clocks exclude applicant hold time · planning totals are estimates

Planning steps and estimates; these are not regulator deadlines.

Botswana Medical Device Registration Process

Step-by-step BoMRA registration process. Total estimated timeline: 2-5 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by BoMRA. Appoint a Local Technical Representative (LTR), also called Authorized Representative — a company residing in or incorporated in Botswana, which is the applicant of record.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to BoMRA including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

BoMRA reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

1-3 months

In-depth technical assessment of device safety and performance. BoMRA may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, BoMRA issues Botswana market authorization certificate.

Summary: The Botswana medical device registration process through Botswana Medicines Regulatory Authority (BoMRA) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
A Reference Regulatory Authority (an NRA recognised by BoMRA under its recognition-and-reliance policy) with a marketing authorisation already grantedThis is the only foreign approval that changes the route: proof of the Reference Regulatory Agency and proof of its marketing authorisation are required dossier items for the abridged pathway (G01 Table 3) and not for the full pathway, and the abridged target is 4-8 months against the full foreign-manufacturer target of 8-12 months. It does not replace BoMRA's own evaluation of the abridged dossier.
WHO Prequalification (WHO Collaborative Registration Procedure)A dedicated WHO CRP row with a published 3-month target in G01 s.4.15, shorter than any other route; the manufacturer must submit the filled form 2 and form 3 with the application.
Stringent Regulatory Authority approval — ICH members (European Commission, US FDA, Japan MHLW/PMDA), ICH observers (Swissmedic, Health Canada) or an authority associated with an ICH member through a legally binding mutual recognition agreement (including Australia, Iceland, Liechtenstein and Norway)The SRA definition in G01 s.3.1.26 is used for dossier and reference purposes rather than as an automatic grant: an SRA approval does not by itself confer a Botswana registration, and it benefits the applicant only through the abridged pathway's proof-of-reference-agency requirement, which is defined by the separate Reference Regulatory Authority concept.
China NMPA medical device registration certificateNo route. The NMPA is not named among the ICH members, observers or mutual-recognition-associated authorities in G01 s.3.1.26, and G01's device guideline names no recognition procedure for it. An NMPA certificate may be filed where the Authority asks for proof of registration in other countries, but it carries no procedural benefit and does not abridge BoMRA's evaluation.
Marketing approval in another SADC state (ZAMRA, SAHPRA, PPB, TMDA)No abridgement. SADC and ZAZIBONA procedures cover medicines, not devices, and there is no regional device approval; a SADC registration is not among the Reference Regulatory Authority requirements BoMRA's device guideline states, so it does not shorten the Botswana route.
Key requirements
  • For the import of medical devices into Botswana, registration of the product and an import licence are both mandatory: the importer must hold a registration certificate for the product and an import licence, and the main requirements for import or export control are identification of a local representative (a registered manufacturer or distributor holding a BoMRA licence), a market authorisation certificate from the country of origin, the import/export licence, and registration of the product.
  • A foreign applicant must appoint a Local Technical Representative (also called an Authorized Representative) which must be a company residing in Botswana or incorporated in Botswana, and the LTR is the applicant of record taking responsibility for compliance (G01 s.3.1.3).
  • Technical dossier submissions are made in electronic format through the BRIMS Self Service Portal, and a separate and complete product dossier is required for each grouping — one single device, device family, device system or device group per application (G01 ss.4.1(i), 4.6 and 4.7).
  • A Class B, C or D application goes through screening first and evaluation second: once the application is accepted and the screening fee paid, processing follows the s.4.15 timeline, and once a query is raised processing halts until the response is received — two query cycles are allowed and no response within the published timeline is deemed withdrawal of the application (G01 s.4.8).
  • Evidence of conformity to the Essential Principles of Safety and Performance must be provided by completing the Essential Principles checklist in BOMRA/ER/MED/P04/G04, identifying the applicable principles and the full title, identifying number and date of each standard applied, with declarations or certificates of conformity to those recognized standards (G01 s.6.2).
  • The Class B, C and D dossier must include proof of a quality management system such as an ISO 13485 certificate or equivalent, the Declaration of Conformity, the Certificate of Compliance with Recognized Standards, a post-market surveillance plan, an executive summary, the Summary Technical Documentation and device labelling (G01 Table 3).
  • A device registration is valid for five years unless suspended or revoked by BoMRA or terminated by the registrant, and its validity is subject to payment of annual retention fees as prescribed in the fee regulations in force, submission of post-marketing surveillance reports and submission of adverse-effect reports associated with the device; renewal applications must be made six months before expiry (G01 ss.4.10 and 4.14).
  • Every consignment must be accompanied by an import permit and an original proforma invoice, devices are inspected on arrival at the ports of entry by BoMRA inspectors or a designate before release, and no importation through ordinary or registered post is sanctioned (BoMRA import/export guideline, s.10).
  • The out-of-scope categories in BoMRA's public notice of 4 September 2026 do not require BoMRA import clearance, permits or registration: industrial-use PPE, external quality assessment and proficiency testing materials, general laboratory equipment for non-clinical use, devices for studies and educational purposes, medical training equipment and simulators, general wellness and fitness devices not intended for clinical diagnosis, disease prevention or hospital treatment, breathalysers and screening equipment not intended for clinical or hospital diagnostic procedures, spare parts and accessories for the repair or servicing of existing equipment, and forensic or law-enforcement test kits.
Keep researching this market
View the Botswana resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against BoMRA publications · full review 2026-09-16 · row IDs are stable — cite as registration-timeline:botswana:screening